Metabolic Solutions Development Company (MSDC) is a drug discovery and development company investigating new molecular targets and developing novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes.

News

5.21.2013

Metabolic Solutions finds diabetes ‘breakthrough’ at life sciences incubator

Insights